Despite significant progress in cancer treatments, the benefits are not experienced equally across different socioeconomic groups.

Tyra Biosciences' shares have dropped sharply after interim data from TYRA-300 showed a superior but not exceptional adverse ...

Physicians are ethically obligated to inform patients about their prognosis so that patients can make cancer treatment ...